ArticleCost effectiveness and resource allocation : C/E2025
Cost-effectiveness analysis of Anastrozole combined with Abemaciclib for the treatment of postmenopausal hormone receptor-positive advanced breast cancer.
Xiaofeng Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.